Yellow Fluorescent Protein-Based Assay to Measure GABAA Channel Activation and Allosteric Modulation in CHO-K1 Cells

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Johansson, Teres ^a   Norris, Tyrrell ^a   Peilot Sjögren, Helena ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; YELLOW FLUORESCENT PROTEIN;

ALLOSTERISM; ANIMAL CELL; ARTICLE; CELL ASSAY; CHO CELL; CONTROLLED STUDY; CRYOPRESERVATION; ELECTROPORATION; FEMALE; GENE SEQUENCE; HIGH THROUGHPUT SCREENING; NONHUMAN; NUCLEOTIDE SEQUENCE; PROCESS DEVELOPMENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE;

ALLOSTERIC REGULATION; ANIMALS; BACTERIAL PROTEINS; BIOLOGICAL ASSAY; CHO CELLS; CRICETINAE; CRICETULUS; ELECTROPORATION; GAMMA-AMINOBUTYRIC ACID; LUMINESCENT PROTEINS; RECEPTORS, GABA-A;

EID: 84875034683     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059429     Document Type: Article

References (24)

1. Sieghart W, Sperk G, (2002) Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem 2: 795-816.
2. Whiting PJ, Bonnert TP, McKernan RM, Farrar S, Bourdelles BL, et al. (1999) Molecular and functional diversity of the expanding GABA-A receptor gene family. Ann N Y Acad Sci 868: 645-653.
3. Chang Y, Wang R, Barot S, Weiss DS, (1996) Stoichiometry of a recombinant GABAA receptor. J Neurosci 16: 5415-5424.
4. Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, et al. (1998) International union of pharmacology. XV. subtypes of γ-aminobutyric AcidA receptors: Classification on the basis of subunit structure and receptor function. Pharmacol Rev 50: 291-314.
5. McKernan RM, Whiting PJ, (1996) Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci 19: 139-143.
6. Atack JR, (2011) GABAA receptor subtype-selective modulators. I. α2/α3-selective agonists as non-sedating anxiolytics. 11: 1176.
7. Rudolph U, Crestani F, Möhler H, (2001) GABAA receptor subtypes: Dissecting their pharmacological functions. Trends Pharmacol Sci 22: 188-194.
8. Smith A, Simpson P, (2003) Methodological approaches for the study of GABAA receptor pharmacology and functional responses. Anal Bioanal Chem 377: 843-851.
9. Wolff C, Fuks B, Chatelain P, (2003) Comparative study of membrane potential-sensitive fluorescent probes and their use in ion channel screening assays. J Biomol Screen 8: 533-543.
10. Mennerick S, Chisari M, Shu H, Taylor A, Vasek M, et al. (2010) Diverse voltage-sensitive dyes modulate GABAAReceptor function. J Neurosci 30: 2871-2879.
11. Galietta LV, Jayaraman S, Verkman AS, (2001) Cell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists. Am J Physiol Cell Physiol 281: C1734-42.
12. Galietta LJV, Haggie PM, Verkman AS, (2001) Green fluorescent protein-based halide indicators with improved chloride and iodide affinities. FEBS Lett 499: 220-224.
13. Sui J, Cotard S, Andersen J, Zhu P, Staunton J, et al. (2010) Optimization of a yellow fluorescent protein-based iodide influx high-throughput screening assay for cystic fibrosis transmembrane conductance regulator (CFTR) modulators. Assay Drug Dev Technol 8: 656-668.
14. Jayaraman S, Haggie P, Wachter RM, Remington SJ, Verkman AS, (2000) Mechanism and cellular applications of a green fluorescent protein-based halide sensor. J Biol Chem 275: 6047-6050.
15. Kruger W, Gilbert D, Hawthorne R, Hryciw D, Frings S, et al. (2005) A yellow fluorescent protein-based assay for high-throughput screening of glycine and GABAA receptor chloride channels. Neurosci Lett 380: 340-345.
16. Phez E, Faurie C, Golzio M, Teissié J, Rols M, (2005) New insights in the visualization of membrane permeabilization and DNA/membrane interaction of cells submitted to electric pulses. Biochim Biophys Acta 1724: 248-254.
17. Gilbert D, Esmaeili A, Lynch J, (2009) Optimizing the expression of recombinant alphabetagamma GABAA receptors in HEK293 cells for high-throughput screening. J Biomol Screen 14: 86-91.
18. Elagoz A, Henderson D, Babu PS, Salter S, Grahames C, et al. (2004) A truncated form of CKbeta8-1 is a potent agonist for human formyl peptide-receptor-like 1 receptor. Br J Pharmacol 141: 37-46.
19. Liu J, Chen T, Norris T, Knappenberger K, Huston J, et al. (2008) A high-throughput functional assay for characterization of gamma-aminobutyric acid(A) channel modulators using cryopreserved transiently transfected cells. Assay Drug Dev Technol 6: 781-786.
20. Gamper N, Stockand JD, Shapiro MS, (2005) The use of chinese hamster ovary (CHO) cells in the study of ion channels. J Pharmacol Toxicol Methods 51: 177-185.
21. Robertson B, (1989) Characteristics of GABA-activated chloride channels in mammalian dorsal root ganglion neurones. J Physiol 411: 285-300.
22. Verdoorn TA, Draguhn A, Ymer S, Seeburg PH, Sakmann B, (1990) Functional properties of recombinant rat GABAA receptors depend upon subunit composition. Neuron 4: 919-928.
23. McCabe C, Shaw D, Atack JR, Street LJ, Wafford KA, et al. (2004) Subtype-selective GABAergic drugs facilitate extinction of mouse operant behaviour. 46: 171-178.
24. Atack JR, Wafford KA, Spencer JT, Cook SM, Sohal B, et al. (2006) TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo z[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates. 316: 410-422.